IBI311 Clinical Trials
4 recruitingDrug
Phase 43Phase 31
Showing 1–4 of 4 trials
Recruiting
Phase 3
A Clinical Study to Evaluate the Efficacy and Safety of IBI311 in Subjects With Inactive Thyroid Eye Disease
Thyroid Eye Disease
Innovent Biologics (Suzhou) Co. Ltd.111 enrolled1 locationNCT07113262
Recruiting
Phase 4
The Safety and Efficacy of Sequential Hormone Therapy and IBI311 Therapy in Patients With Active Moderate to Severe TAO in the Initial Treatment.
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital64 enrolled2 locationsNCT07152340
Recruiting
Phase 4
Evaluation of the Efficacy and Safety Observation of IBI311 Treatment in Patients With Inactive TAO
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital50 enrolled1 locationNCT07152392
Recruiting
Phase 4
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
Thyroid Associated Ophthalmopathies
Shanghai Changzheng Hospital96 enrolled1 locationNCT07152366